This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Shionogi Company Limited. Active years: 2003-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Koka-gun, JP (2003 - 2005)
- Osaka, JP (2011)
Company Filing History:
Years Active: 2003-2011
Title: Goro Katsuura: Innovator in Pharmaceutical Composition
Introduction
Goro Katsuura is a notable inventor based in Koka-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders. With a total of 3 patents to his name, Katsuura's work is recognized for its innovative approaches to complex medical conditions.
Latest Patents
Katsuura's latest patents include a pharmaceutical composition aimed at treating spinocerebellar ataxia and multiple system atrophy. This invention comprises a compound of a specific formula, where R can be methyl, cyano, or carbamoyl, serving as an active ingredient. Another notable patent involves cyclic amine derivatives, which are utilized as an antiobesity agent and a preventive or therapeutic agent for diabetes. This composition contains a compound of a defined formula, featuring substituted aryl or heteroaryl groups.
Career Highlights
Goro Katsuura is associated with Shionogi Company Limited, where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the creation of effective treatments for debilitating conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Katsuura has collaborated with esteemed colleagues, including Toshisada Yano and Isako Sakaguchi. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Goro Katsuura's contributions to pharmaceutical inventions highlight his role as a key innovator in the industry. His patents reflect a dedication to addressing significant health challenges through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
